EUVIMEDEUVIMED entdecken
Crossref

Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases

Alexandros Panagiotopoulos iD, George E Fragoulis iD, Aikaterini Arida, Vassiliki-Kalliopi Bournia iD, Gerasimos Evangelatos iD, Kalliopi Fragkiadaki iD, Evrydiki Kravvariti iD, Katerina Laskari iD, Maria Mylona iD, Nikolaos Michalakeas, Nikolaos Papazoglou iD, Maria Pappa iD und 6 weitere

Rheumatology International · 2024

DOI: 10.1007/s00296-024-05573-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology International, 2024. Verfasst von Alexandros Panagiotopoulos und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Propaedeutic Internal Medicine, School of Medicine, Joint Academic Rheumatology Program, National and Kapodistrian University of Athens…. Hauptthemen laut MEDLINE: COVID-19, Rheumatic Diseases, Hospitalization, Reinfection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data on COVID-19 re-infections in patients with systemic rheumatic diseases (SRDs) are lacking. We aimed to describe the course and outcomes of COVID-19 re-infections in these patients versus controls. In this single-center retrospective study, we included 167 consecutive SRD patients with at least one COVID-19 re-infection (mean age 47.3 years, females 70.7%). SRD patients were compared in terms of patient-perceived COVID-19 re-infection severity and hospitalizations/deaths with 167 age/sex-matched non-SRD controls. Logistic regression analysis was performed to assess potential milder re-infection versus primary infection severity, adjusting for study group, demographics (age, sex), vaccination status, body mass index, smoking, and comorbidities. 23 and 7 out of 167 re-infected SRD patients experienced two and three re-infections, respectively, which were comparable to the re-infection rates in controls (two: 32; and three: 2) who also had comparable COVID-19 vaccination history (89% and 95% vaccinated, respectively). In the initial infection, patients with SRDs were hospitalized (7.2% versus 1.8%, p = 0.017), and had received antiviral treatment (16.1% versus 4.7%, p 0.05) between patients and controls at the first re-infection, as well as during the second and third re-infection; no deaths were recorded. Perceived severity of re-infections was also comparable between patients and controls (p = 0.847) and among those on biologic DMARDs or not (p = 0.482). In multivariable analysis, neither SRDs presence nor demographics or comorbidities were associated with COVID-19 re-infection severity. COVID-19 re-infection severity (patient-perceived/hospitalizations/deaths) did not differ between SRDs and controls.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Rheumatic DiseasesHospitalizationReinfectionSARS-CoV-2HumansFemaleMaleMiddle AgedRetrospective StudiesAdultSeverity of Illness IndexComorbidityAged

Stichwörter der Autor:innen

COVID-19Re-infectionsRheumatic diseases

Autor:innen und Institutionen

  • Department of Propaedeutic Internal Medicine, School of Medicine, Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, Mikras Asias 75 Str, Athens, Greece.
  • Department of Propaedeutic Internal Medicine, School of Medicine, Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, Mikras Asias 75 Str, Athens, Greece. geofragoul@yahoo.gr.

ORCID-Profile: Alexandros Panagiotopoulos, George E Fragoulis, Vassiliki-Kalliopi Bournia, Gerasimos Evangelatos, Kalliopi Fragkiadaki, Evrydiki Kravvariti, Katerina Laskari, Maria Mylona, Nikolaos Papazoglou, Maria Pappa, Stylianos Panopoulos, Maria G Tektonidou, Petros P Sfikakis

Zitieren

APA

Panagiotopoulos, A., Fragoulis, G. E., Arida, A., Bournia, V. K., Evangelatos, G., Fragkiadaki, K., Kravvariti, E., Laskari, K., Mylona, M., Michalakeas, N., Papazoglou, N., Pappa, M., Poulia, V., Panopoulos, S., Ziarangali, S., Papatheodorou, V., Tektonidou, M. G., & Sfikakis, P. P. (2024). Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases. Rheumatology International. https://doi.org/10.1007/s00296-024-05573-w

Vancouver

Panagiotopoulos A, Fragoulis GE, Arida A, Bournia VK, Evangelatos G, Fragkiadaki K, et al. Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases. Rheumatology International. 2024. doi:10.1007/s00296-024-05573-w

BibTeX
@article{Panagiotopoulos2024,
  author = {Panagiotopoulos, Alexandros and Fragoulis, George E and Arida, Aikaterini and Bournia, Vassiliki-Kalliopi and Evangelatos, Gerasimos and Fragkiadaki, Kalliopi and Kravvariti, Evrydiki and Laskari, Katerina and Mylona, Maria and Michalakeas, Nikolaos and Papazoglou, Nikolaos and Pappa, Maria and Poulia, Vassiliki and Panopoulos, Stylianos and Ziarangali, Sevastiani and Papatheodorou, Vasileios and Tektonidou, Maria G and Sfikakis, Petros P},
  title = {Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases},
  journal = {Rheumatology International},
  year = {2024},
  doi = {10.1007/s00296-024-05573-w}
}
Kostenlos starten →